Ekso Bionics Q2 revenue misses estimates, net loss widens
Overview
Ekso Bionics Q2 revenue of $2.1 mln missed analyst expectations
Company reported net loss of $2.7 mln for Q2 2025
Personal Health product sales grew over 50% yr/yr in H1 2025
Outlook
Ekso anticipates recovery in H2 driven by Personal Health demand
Ekso sees over 50% growth in Personal Health products Y-o-Y
Company aims to meet anticipated Enterprise Health customer demand
Result Drivers
ENTERPRISE HEALTH SALES - Revenue decline attributed to short-term delays in completing multi-device Enterprise Health sales, per CEO Scott Davis
PERSONAL HEALTH GROWTH - Personal Health product sales grew over 50% year-over-year in H1 2025
GROSS MARGIN PRESSURE - Gross margin decreased due to fixed costs and increased shipping costs, partially offset by improved service margins
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Revenue | Miss | $2.06 mln | $4.31 mln (2 Analysts) |
Q2 EPS |
| -$1.24 |
|
Q2 Net Ioss |
| $2.71 mln |
|
Q2 Operating Expenses |
| $4.79 mln |
|
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"
Wall Street's median 12-month price target for Ekso Bionics Holdings Inc is $37.50, about 87.1% above its July 25 closing price of $4.82
Press Release: ID:nGNX6yKn6m
Related Articles
U.S. September Rate Decision Preview: What It Means for Bitcoin and Could It Spark a New Rally?
Bitcoin’s rally stalls ahead of the Fed meeting — has the bullish momentum already been priced in?
UK July GDP Commentary: Can GBP Break Through Its Current Fluctuation?
After considering multiple factors, given the evident weakness on both sides of this currency pair, we expect the GBP/USD exchange rate to maintain its current fluctuation trend in the short term.
[Reuters Analysis] Trump adopts messenger-in-chief role after Charlie Kirk's death
By Trevor Hunnicutt and Steve Holland WASHINGTON, Sept 14 (Reuters) - Since the U.S. conservative activist Charlie Kirk was shot in a brazen display of violence, President Donald Trump has embraced the role of spokesman in an extraordinary way.Trump was first to confirm the news to a country in s
Investing in Specialized Real Estate
TradingKey - Niche assets like data centers, logistics, healthcare, and cold storage thrive on structural drivers, not traditional property cycles Specialized real estate benefits from secular trends like digitalization, demographics, and supply chain innovation
Fed to Cut Rates: All Asset Prices Up!
TradingKey - The Federal Reserve is almost certain to restart its interest rate cut cycle on 17 September this year. After in-depth research, we have concluded that cryptocurrencies, the broader U.S. stock market, and short-term U.S. Treasury bonds will all go up.
